154 related articles for article (PubMed ID: 1320708)
1. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
Matsumoto S; Shindo J; Horiba M; Hara M; Inoue K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
[TBL] [Abstract][Full Text] [Related]
2. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
Niitsu N; Umeda M
Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of six potential serum markers of hepatic fibrosis in alcoholic disease of the liver].
Grimbert S; Trinchet JC; Hartmann DJ; Munz C; Garnier M; Mal F; Callard P; Beaugrand M
Gastroenterol Clin Biol; 1993; 17(8-9):570-7. PubMed ID: 8253314
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U
Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts].
Behr J; Adelmann-Grill BC; Hein R; Schwaiblmair M; Degenkolb B; Krombach F; Fruhmann G
Pneumologie; 1995 Apr; 49(4):266-72. PubMed ID: 7792285
[TBL] [Abstract][Full Text] [Related]
6. Elevation of laminin and beta-subunit of prolyl 4-hydroxylase in the sera of human subjects with Schistosomiasis mansoni.
Tanabe M; Sekiguchi T; Kaneko N; Kobayashi S; Takeuchi T; Coutinho A; Tateno S; Maruyama K; Okazaki I
Jpn J Exp Med; 1989 Jun; 59(3):109-19. PubMed ID: 2554032
[TBL] [Abstract][Full Text] [Related]
7. [Serum type III procollagen N-terminal peptide in patients with collagen diseases].
Aoki A; Hagiwara E; Atsumi Y; Shirai A; Igarashi T; Narita M; Matsunaga K; Ishigatsubo Y; Tani K; Okubo T
Ryumachi; 1990 Apr; 30(2):81-4. PubMed ID: 2173157
[TBL] [Abstract][Full Text] [Related]
8. [N-terminal peptide of type III procollagen in serum and bronchoalveolar fluid as a marker of collagen metabolism in chronic interstitial lung diseases].
Siemińska A
Przegl Lek; 1996; 53(7):574-8. PubMed ID: 8975295
[TBL] [Abstract][Full Text] [Related]
9. [Hepatic fibrosis and its serum markers].
Okabe K
Rinsho Byori; 1992 Dec; 40(12):1258-64. PubMed ID: 1339165
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
11. Serum lysyl oxidase activity in chronic liver disease in comparison with serum levels of prolyl hydroxylase and laminin.
Murawaki Y; Kusakabe Y; Hirayama C
Hepatology; 1991 Dec; 14(6):1167-73. PubMed ID: 1683640
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis.
Milman N; Kristensen MS; Bentsen K; Grode G; Frederiksen J
Sarcoidosis; 1995 Mar; 12(1):38-41. PubMed ID: 7617974
[TBL] [Abstract][Full Text] [Related]
13. Type III procollagen N-terminal peptides in experimental pulmonary fibrosis and human respiratory diseases.
Watanabe Y; Yamaki K; Yamakawa I; Takagi K; Satake T
Eur J Respir Dis; 1985 Jul; 67(1):10-6. PubMed ID: 2414122
[TBL] [Abstract][Full Text] [Related]
14. Laminin fragment P1 is increased in the lower respiratory tract of patients with diffuse interstitial lung diseases.
Pérez-Arellano JL; Pedraz MJ; Fuertes A; de la Cruz JL; González de Buitrago JM; Jiménez A
Chest; 1993 Oct; 104(4):1163-9. PubMed ID: 8404185
[TBL] [Abstract][Full Text] [Related]
15. Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis.
Low RB; Cutroneo KR; Davis GS; Giancola MS
Lab Invest; 1983 Jun; 48(6):755-9. PubMed ID: 6855198
[TBL] [Abstract][Full Text] [Related]
16. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease.
Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J
Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of lymphocytes and PIIINP with the combined pulmonary fibrosis and emphysema].
Wei XH; Wu XY; Wang JH; Thakur A; Ma AQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):675-8. PubMed ID: 20619092
[TBL] [Abstract][Full Text] [Related]
18. Type III and type I procollagen markers in fibrosing alveolitis.
Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Kahlos K; Lähde S; Kinnula V
Am J Respir Crit Care Med; 1999 Mar; 159(3):818-23. PubMed ID: 10051256
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of extracellular matrix in acute pancreatitis.
Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S
Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions.
Gressner AM; Tittor W; Negwer A
Hepatogastroenterology; 1986 Oct; 33(5):191-5. PubMed ID: 3804173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
